Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Exelixis
Company Monitoring Page for Exelixis
latest headlines for company on cafepharma
Analysts throw cold water on Exelixis and Roche's prostate cancer data, putting the pair a further step behind Novartis
Endpoints
Tue, 05/25/21 - 11:08 am
Tags:
Exelixis
,
Cabometyx
,
Roche
,
Tecentriq
,
prostate cancer
ASCO 2021: Watch for Sanofi/Sloan Kettering, Incyte, Exelixis and AstraZeneca
BioSpace
Thu, 05/20/21 - 12:35 pm
Tags:
ASCO 2021
,
Sanofi
,
Sloane Kettering
,
Incyte
,
AstraZeneca
,
Exelixis
,
oncology
ASCO: Exelixis releases more details on Cabometyx thyroid cancer data that wooed Ipsen
Fierce Pharma
Thu, 05/20/21 - 12:15 pm
Tags:
ASCO 2021
,
Ipsen
,
Exelixis
,
Cabometyx
,
thyroid cancer
,
clinical trials
Exelixis' Cabometyx scores backing from Ipsen in thyroid cancer, with full data release set for ASCO
Fierce Pharma
Wed, 05/12/21 - 11:39 pm
Tags:
Exelixis
,
Cabometyx
,
Ipsen
,
thyroid cancer
Bristol Myers, Exelixis snag Opdivo-Cabometyx kidney cancer nod to challenge Merck, Pfizer
Fierce Pharma
Mon, 01/25/21 - 11:09 am
Tags:
Bristol-Myers Squibb
,
Exelixis
,
Opdivo
,
Cabometyx
,
kidney cancer
,
FDA
Exelixis Gets FDA Approval for Cabometyx in Combination Therapy for Front-Line RCC
Motley Fool
Sat, 01/23/21 - 11:35 pm
Tags:
Exelixis
,
FDA
,
Cabometyx
,
Cometriq
,
advanced renal cell carcinoma
Exelixis, NBE join forces for discovery and development of ADCs for cancer
Pharmaceutical Business Review
Wed, 09/9/20 - 10:32 am
Tags:
Exelixis
,
NBE Therapeutics
,
antibody-drug conjugate
,
oncology
Exelixis Files for Cabometyx Combo in First-Line Kidney Cancer
Yahoo/Zacks.com
Tue, 08/25/20 - 11:19 am
Tags:
Exelixis
,
Cabometyx
,
FDA
,
kidney cancer
,
renal cell carcinoma
,
Bristol-Myers Squibb
,
Opdivo
Exelixis initiates phase 3 trial of Cabozantinib/Atezolizumab combo in prostate cancer
Pharmaceutical Business Review
Wed, 07/1/20 - 11:03 am
Tags:
Exelixis
,
cabozantinib
,
Cabometyx
,
Tecentriq
,
metastatic castration-resistant prostate cancer
,
clinical trials
Exelixis lands PhIII kidney cancer win with Bristol Myers in their hunt for $4 billion
Endpoints
Mon, 04/20/20 - 11:59 pm
Tags:
Bristol-Myers Squibb
,
Opdivo
,
Exelixis
,
Cabometyx
,
renal cell carcinoma
,
kidney cancer
,
clinical trials
2 Biotechs Battling Against Kidney Cancer
Motley Fool
Sun, 04/19/20 - 11:06 pm
Tags:
kidney cancer
,
Nektar
,
Exelixis
Why AnaptysBio, bluebird bio, and Exelixis Shares Rebounded Last Friday
Motley Fool
Mon, 03/16/20 - 10:31 am
Tags:
pharma stocks
,
AnaptysBio
,
Bluebird Bio
,
Exelixis
,
COVID-19
Asco-GU 2020: revving up for Peloton deal validation
EP Vantage
Thu, 02/13/20 - 10:46 am
Tags:
ASCO-GU 2020
,
Merck
,
Peloton Therapeutics
,
Exelixis
Exelixis Reports Positive Results in Metastatic Castration-Resistant Prostate Cancer Study
Motley Fool
Wed, 02/12/20 - 10:27 am
Tags:
Exelixis
,
prostate cancer
,
metastatic castration-resistant prostate cancer
,
cabozantinib
,
Cabometyx
JP Morgan Preview: Small, Medium and Large, with a Lot of M&A Speculation
BioSpace
Mon, 01/13/20 - 11:08 am
Tags:
JPMHC 2020
,
M&A
,
Exelixis
,
Intercept Pharmaceuticals
,
Avidity Biosciences
,
Theravance
,
Moderna Therapeutics
,
Kodiak Sciences
Eyeing second Japanese approval, Daiichi and Exelixis announce positive pivotal for kidney drug
Endpoints
Fri, 11/8/19 - 10:40 am
Tags:
Daiichi Sankyo
,
Exelixis
,
clinical trials
,
diabetic nephropathy
,
Minnebro
Renal Cell Carcinoma Space in Focus: Some Key Developments
Yahoo/Zacks.com
Sat, 09/14/19 - 11:18 am
Tags:
renal cell carcinoma
,
kidney cancer
,
Exelixis
,
Roche
,
Merck
,
Aveo Oncology
Exelixis Hits Blockbuster Status
Motley Fool
Mon, 08/5/19 - 10:45 am
Tags:
Exelixis
,
cabozantinib
,
Cabometx
,
kidney cancer
,
liver cancer
,
Cometriq
,
thyroid cancer
Exelixis Bolsters Pipeline in Deal with India's Aurigene
BioSpace
Fri, 08/2/19 - 12:20 am
Tags:
Exelixis
,
Indian
,
Aurigene
,
Cabometyx
Roche/Exelixis' Cotellic fizzles in pivotal melanoma study
Endpoints
Fri, 06/21/19 - 10:07 am
Tags:
Roche
,
Exelixis
,
Cotellic
,
Tecentriq
,
clinical trials
,
advanced melanoma
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.